NCT03071770View on ClinicalTrials.gov

Japanese Bridging Study of Ivosidenib (AG-120) in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

March 31, 2017

Primary Completion Date

May 9, 2017

Study Completion Date

September 6, 2017

Conditions
Healthy
Interventions
DRUG

ivosidenib (AG-120)

A single-dose of ivosidenib (AG-120) administered in healthy Japanese and Caucasian subjects

Trial Locations (1)

90630

West Coast Clinical Trial (WCCT), Cypress

Sponsors
All Listed Sponsors
lead

Agios Pharmaceuticals, Inc.

INDUSTRY